Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Renal Insufficiency × Calcium Dobesilate × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Recurrence 4 Burkitt Lymphoma 4 Leukemia, Biphenotypic, Acute 3 Immunoglobulin Light-chain Amyloidosis 3 Lymphoma, B-Cell 2 Lymphoma 2 Hodgkin Disease 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Waldenstrom Macroglobulinemia 1 Smoldering Multiple Myeloma 1 Renal Insufficiency 1 Proteostasis Deficiencies 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Meningioma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphodepleting Chemotherapy 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia 1 Hematologic Neoplasms 1 Cytokine Release Syndrome 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 3 Dexamethasone 2 Bortezomib 2 isatuximab 1 gallium 68 PSMA-11 1 Whole-Body Irradiation 1 Standard of Care 1 Pluvicto 1 Kidney Transplantation 1 Gemcitabine 1 Eplerenone 1 Calcium Dobesilate 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04240054 2026-01-28

VICD

Medical College of Wisconsin

Phase 2 Recruiting

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡